| Variable | CPFE (n = 22) | IPF (n = 8) | Emphysema (n = 17) | p-value |
|---|---:|---:|---:|---:|
| Age, years — Median | 73.5 | 74 | 78 | 0.6949 |
| Age, years — Range | 60–95 | 55–88 | 50–84 |  |
| Gender, F/M | 0/22 | 1/7 | 2/15 | 0.244 |
| Smoking history, pack years — Median | 64 | 43 | 75 | 0.6405 |
| Smoking history, pack years — Range | 20–200 | 30–120 | 15–150 |  |
| Pulmonary function test — VC (L) | 2.52 ± 0.72 | 2.34 ± 0.86 | 2.85 ± 0.61 | 0.5175 |
| %VC | 83.1 ± 22.1 | 68.0 ± 27.7 | 87.0 ± 12.4 | 0.2920 |
| FEV1 (L) | 2.01 ± 0.19 | 1.60 ± 0.24 | 1.57 ± 0.22 | 0.281 |
| FEV1/FVC (%) | 76.8 ± 3.31 | 81.8 ± 4.45 | 55.6 ± 4.06 | 0.0007 |
| DLCO (mL/min/mmHg) | 6.30 ± 3.89 | 9.68 ± 3.65 | 15.45 ± 6.34 | 0.0149 |
| %DLCO | 36.6 ± 17.5 | 52.1 ± 27.7 | 102.5 ± 58.1 | 0.0153 |
| DLCO/VA | 1.96 ± 0.77 | 2.97 ± 0.26 | 3.06 ± 1.48 | 0.1428 |
| %DLCO/VA | 44.0 ± 16.8 | 69.1 ± 10.1 | 69.3 ± 30.6 | 0.0988 |
| Treatment for IP — Corticosteroids | 14 (63.6%) | 6 (75%) | - | 0.452 |
| Treatment for IP — Immunosuppressive agent | 1 (4.5%) | 0 | - | 0.733 |
| Treatment for IP — Long-term oxygen | 5 (22.7%) | 1 (12.5%) | - | 0.48 |
| Cause of death — Lung cancer | 9 (40.9%) | 1 (12.5%) | 13 (81.3%) | 0.007 |
| Cause of death — Acute exacerbation of IP | 6 (27.2%) | 2 (25.0%) | 0 (0%) | 0.091 |
| Cause of death — Infection | 4 (18.1%) | 1 (12.5%) | 1 (6.3%) | 0.521 |
| Cause of death — Heart failure | 2 (9.1%) | 0 | 2 (12.5%) | 0.611 |
| Cause of death — Other causes | 1 (4.5%) | 1 (12.5%) | 1 (6.3%) | 0.729 |

Table: Clinical characteristics, pulmonary function test results, treatments for interstitial pneumonia (IP), and causes of death for CPFE, IPF, and Emphysema groups.
